These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38573642)

  • 1. Immunotherapy in Gastric Cancer-Choosing Methods or Results.
    Alcindor T
    JAMA Oncol; 2024 Jun; 10(6):704-705. PubMed ID: 38573642
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological contributions to the management of gastric cancer.
    Guillou PJ; Monson JR
    Hepatogastroenterology; 1989 Apr; 36(2):86-91. PubMed ID: 2659484
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunotherapeutic advances in gastric cancer.
    Yoneda A; Kuroki T; Eguchi S
    Surg Today; 2021 Nov; 51(11):1727-1735. PubMed ID: 33590326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of adjuvant chemotherapy and immunotherapy in gastric cancer.
    Labianca R; Panvini D
    Pathol Biol (Paris); 1993 Jan; 41(1):80-1. PubMed ID: 8316482
    [No Abstract]   [Full Text] [Related]  

  • 5. Interpatient variability in mesothelin expression necessitates its evaluation before gastric cancer immunotherapy.
    Sotoudeh M; Mansouri V; Shakeri R; Sharififard B; Sajadi N; Naderi M
    Immunotherapy; 2022 May; 14(7):531-538. PubMed ID: 35321580
    [No Abstract]   [Full Text] [Related]  

  • 6. Strategies and Advancements in Harnessing the Immune System for Gastric Cancer Immunotherapy.
    Subhash VV; Yeo MS; Tan WL; Yong WP
    J Immunol Res; 2015; 2015():308574. PubMed ID: 26579545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy in gastric cancer.
    Matsueda S; Graham DY
    World J Gastroenterol; 2014 Feb; 20(7):1657-66. PubMed ID: 24587645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy in advanced gastric cancer, is it the future?
    Coutzac C; Pernot S; Chaput N; Zaanan A
    Crit Rev Oncol Hematol; 2019 Jan; 133():25-32. PubMed ID: 30661655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific immunotherapy for non-curatively resected gastric cancer.
    Ishikawa Y; Kakuta H; Fukushima M; Machida S; Fukuda S
    Jpn J Surg; 1979 Sep; 9(3):180-9. PubMed ID: 470250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal Anti-tumor Approaches Combined with Immunotherapy to Overcome Tumor Resistance in Esophageal and Gastric Cancer.
    Bolm L; Käsmann L; Paysen A; Karapetis C; Rades D; Wellner UF; Keck T; Watson DI; Hummel R; Hussey DJ
    Anticancer Res; 2018 Jun; 38(6):3231-3242. PubMed ID: 29848670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for gastric cancer: problems and prospects.
    Steele RJ; Lane DP
    Surg Oncol; 2000 Jul; 9(1):13-6. PubMed ID: 11525301
    [No Abstract]   [Full Text] [Related]  

  • 12. Salvage systemic therapy for advanced gastric and oesophago-gastric junction adenocarcinoma.
    Tomita Y; Moldovan M; Chang Lee R; Hsieh AH; Townsend A; Price T
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD012078. PubMed ID: 33210731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric cancer and the epoch of immunotherapy approaches.
    Niccolai E; Taddei A; Prisco D; Amedei A
    World J Gastroenterol; 2015 May; 21(19):5778-93. PubMed ID: 26019442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy for Gastric Cancer: Time for a Personalized Approach?
    Dolcetti R; De Re V; Canzonieri V
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29844297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy for oesophagogastric cancer.
    Davidson M; Chau I
    Expert Opin Biol Ther; 2016 Oct; 16(10):1197-207. PubMed ID: 27409159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive Status of Epstein-Barr Virus as a Biomarker for Gastric Cancer Immunotherapy: A Prospective Observational Study.
    Xie T; Liu Y; Zhang Z; Zhang X; Gong J; Qi C; Li J; Shen L; Peng Z
    J Immunother; 2020 May; 43(4):139-144. PubMed ID: 32134806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impressive response to immunotherapy in a metastatic gastric cancer patient: could somatic copy number alterations help patient selection?
    Dos Santos Fernandes G; da Motta Girardi D; Dib Batista Bugiato Faria L; Giacomini Bernardes JP; de Almeida Coudry R
    J Immunother Cancer; 2017 Nov; 5(1):84. PubMed ID: 29157298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adjuvant treatment of cancers of the stomach].
    Bedenne L
    Gastroenterol Clin Biol; 1994; 18(8-9):733-6. PubMed ID: 7875442
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunotherapy for gastric cancer: dilemmas and prospect.
    Zhao Q; Cao L; Guan L; Bie L; Wang S; Xie B; Chen X; Shen X; Cao F
    Brief Funct Genomics; 2019 Mar; 18(2):107-112. PubMed ID: 30388190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review: Gastric cancer: Basic aspects.
    Resende C; Gomes CP; Machado JC
    Helicobacter; 2020 Sep; 25 Suppl 1():e12739. PubMed ID: 32918356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.